FILING ANALYSIS · THURSDAY, OCTOBER 29
Merck & Co., Inc. MRK — 8-K: Results of Operations and Financial Condition
neutral
Merck & Co., Inc. reported third-quarter 2026 financial results, with total worldwide sales of $18.1 billion, representing 5% growth, and non-GAAP EPS of $2.49, including a one-time charge of $0.12 per share related to a global license agreement with SciBrunch. The company narrowed and raised its full-year 2026 financial outlook, expecting sales to be between $66.8 billion and $67.3 billion and no
How we read impact: we grade every directional call in the open. Impact labels are AI estimates — not investment advice. See the full disclaimer.
Get filings like this every market day
The US SEC filings, UK RNS, EU notices, and Polymarket odds that matter — scored by AI, in one email.
Subscribe free →